Opening book details…
Can I read Nanobodies as Structural Probes of Protein Misfolding and Fibril Formation on EtoBox?
Nanobodies as Structural Probes of Protein Misfolding and Fibril Formation by Erwin De Genst; Christopher M. Dobson is a book available to read on EtoBox.
What is Nanobodies as Structural Probes of Protein Misfolding and Fibril Formation about?
The deposition of peptides and proteins as amyloid fibrils is a common feature of nearly 50 medical -disorders affecting the brain or a variety of other organs and tissues. These disorders, which include Alzheimer's disease, Parkinson's disease, the prion diseases, and type II diabetes, have an enormous impact on the public health and economy of the modern world. Extensive research is therefore taking place to determine the underlying molecular mechanisms and determinants of the pathological conversion of amyloidogenic proteins from their soluble forms into fibrillar structures. The use of molecular probes and biophysical techniques, such as X-ray crystallography and particularly NMR spectroscopy, are allowing detailed analysis of the mechanism of fibril formation and of the underlying structural and chemical features of the associated pathogenicity. Nanobodies, the antigen-binding domains derived from camelid heavy-chain antibodies, are excellent tools to probe protein aggregation as a result of their exquisite specificity and high affinity and stability, along with their ease of expression and small size; the latter in particular allows them to be used very efficiently in combina
- Author
- Erwin De Genst; Christopher M. Dobson
- Publisher
- Springer New York : Imprint: Humana Press
- Published
- 2012
- Language
- EN
- ISBN
- 9781617799686
- Subjects
- Medical, Science, Medicine
More by Erwin De Genst; Christopher M. Dobson
Browse all works by Erwin De Genst; Christopher M. Dobson
Similar books
- Protein and Peptide Folding, Misfolding, and Non-Folding — edited by Reinhard Schweitzer-Stenner (2012)
- Protein Misfolding in Neurodegenerative Diseases: Mechanisms and Therapeutic Strategies (Enzyme Inhibitors) — H. John Smith; Claire Simons; Robert D. E Sewell (2008)
- Protein Chaperones and Protection from Neurodegenerative Diseases (Wiley Series in Protein and Peptide Science) — Stephan N. Witt (2011)
- Blue Native PAGE and Mass Spectrometry as an Approach for the Investigation of Stable and Transient Protein-Protein Interactions — Silvana Andreescu; Maria Hepel; Saikat Sen; Raja Chakraborty; L. Gil del Valle; Klaudia Jomova; Marian Valko; Eleanor G. Rogan; Ercole L. Cavalieri; Hsiao C. Wang; Julia L. Brumaghim; Magdalena Stobiecka; Janet Peachey; Jeremiah Miller; Amanda Prance; Kaitlin Coopersmith; Erica Sharpe; Daniel Andreescu; A. Y. Estevez; J. S. Erlichman; Szilveszter Gáspár; Serban F. Peteu; Saleem Banihani; Mutha M. Gunesekera; Pubudu Peiris; Oana A. Sicuia; Mekki Bayachou; Alisa G. Woods; Izabela Sokolowska; Rama Yakubu; Melissa Butkiewicz; Martin LaFleur; Christopher Talbot; Costel C. Darie; Jessica Wagner; Jeannette Dorler; Kelly Wormwood; Johannes Thome (2011)
- Pore-forming Peptides and Protein Toxins (Cellular and Molecular Mechanisms of Toxic Action) — Gianfranco Menestrina; Mauro Dalla Serra; Philip Lazarovici (2003)
- PROTEIN ABNORMALITIES VOLUME 2 PATHOLOGY OF IMMUNOGLOBULINS DIAGNOSTIC AND CLINICAL ASPECTS — Stephan E. Ritzmann; Lawrence M. Killingsworth (1982)